# FDA Inspection 1069022 - Biomat USA, Inc. - September 21, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/0b2ae0d6-1992-468d-8e85-0afb746d9cfb
Source feed: FDA_Inspections

> FDA Inspection 1069022 for Biomat USA, Inc. on September 21, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069022
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-09-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 959868 - 2016-01-27](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/1b891ba4-7a8e-42a6-b803-493a0f97153b)
- [FDA Inspection 878532 - 2014-05-14](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/038cebc0-245b-4859-893d-f11a7e64daae)
- [FDA Inspection 786511 - 2012-06-15](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/a4434d93-9fcc-49da-b3aa-ed7b2e01cf3d)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/84dc02e0-d33b-44fc-ad5f-aa9e9d627105

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d